Detalles de la búsqueda
1.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat
; 202(3): 473-483, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37688665
2.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 53(3): 203-211, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484305
3.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 52(6): 545-553, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296894
4.
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.
Breast Cancer Res Treat
; 184(2): 585-596, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816191
5.
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
Ann Surg Oncol
; 26(8): 2475-2485, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102090
6.
[A Case of Metaplastic Squamous Cell Carcinoma of the Breast Diagnosed after Neoadjuvant Chemotherapy].
Gan To Kagaku Ryoho
; 45(7): 1101-1103, 2018 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-30042281
7.
[Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial].
Gan To Kagaku Ryoho
; 45(12): 1725-1728, 2018 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-30587728
8.
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
Breast Cancer Res Treat
; 156(3): 485-494, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27048417
9.
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
Breast Cancer Res Treat
; 160(1): 163-172, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27647460
10.
[Effect of weekly paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide as neoadjuvant treatment for patients with triple-negative and luminal-type breast cancer - a multicenter study].
Gan To Kagaku Ryoho
; 42(1): 45-50, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25596678
11.
Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literature.
Surg Case Rep
; 9(1): 152, 2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37656266
12.
Multiple angiosarcomas of both breasts: a case report.
Surg Case Rep
; 9(1): 205, 2023 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015377
13.
Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06).
Cancer Med
; 12(17): 17718-17730, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525895
14.
[A multicenter study of epirubicin-docetaxel(ET)as primary chemotherapy for patients with inflammatory breast cancer(IBC)].
Gan To Kagaku Ryoho
; 39(7): 1075-9, 2012 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-22790042
15.
[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].
Gan To Kagaku Ryoho
; 39(5): 747-52, 2012 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-22584325
16.
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.
Breast Cancer Res Treat
; 128(3): 775-81, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21638048
17.
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer.
Breast Cancer Res Treat
; 126(2): 443-51, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21221770
18.
Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study.
Anticancer Drugs
; 21(4): 453-8, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20075712
19.
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer.
Anticancer Res
; 40(8): 4779-4785, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727805
20.
Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.
Breast Cancer
; 27(1): 85-91, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327134